|
PRRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53292999999222E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.23250000000097E-05 |
| Normal-vs-Stage2 |
7.495900E-03 |
| Normal-vs-Stage3 |
5.80909999999824E-05 |
| Normal-vs-Stage4 |
3.75110000000456E-05 |
| Stage1-vs-Stage2 |
7.505800E-01 |
| Stage1-vs-Stage3 |
4.110200E-01 |
| Stage1-vs-Stage4 |
2.004400E-01 |
| Stage2-vs-Stage3 |
4.270200E-01 |
| Stage2-vs-Stage4 |
2.303200E-01 |
| Stage3-vs-Stage4 |
5.714800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85543999999815E-05 |
| Normal-vs-AfricanAmerican |
2.326200E-02 |
| Normal-vs-Asian |
2.435400E-04 |
| Caucasian-vs-AfricanAmerican |
6.468400E-01 |
| Caucasian-vs-Asian |
7.216200E-01 |
| AfricanAmerican-vs-Asian |
4.965600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.19579999999731E-05 |
| Normal-vs-Female |
2.07279999999699E-05 |
| Male-vs-Female |
6.746400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.375200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.5490399999929E-05 |
| Normal-vs-Age(61-80Yrs) |
3.69610000000575E-05 |
| Normal-vs-Age(81-100Yrs) |
2.787400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.933370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.354400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.231000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.294200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.627800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.390200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.202600E-01 |
| Classical-VS-Follicular |
1.177430E-01 |
| Classical-VS-Other |
1.159560E-01 |
| Classical-VS-Normal |
2.837000E-04 |
| Tall-VS-Follicular |
8.458800E-01 |
| Tall-VS-Other |
2.380000E-01 |
| Tall-VS-Normal |
2.296800E-03 |
| Follicular-VS-Other |
3.316600E-01 |
| Follicular-VS-Normal |
8.08130000000684E-05 |
| Other-VS-Normal |
5.583000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9489299999953E-05 |
| Normal-vs-N1 |
4.26370000000675E-05 |
| N0-vs-N1 |
5.534600E-01 |
|
|
